Epidemiology, clinical manifestations, and hematological features of pediatric acute myeloid leukemia in Uganda: a retrospective study - Takeaways - MDSpire

Epidemiology, clinical manifestations, and hematological features of pediatric acute myeloid leukemia in Uganda: a retrospective study

  • By

  • Richard Nyeko

  • Mariana Kruger

  • Nixon Niyonzima

  • Barnabas Atwiine

  • Jennifer Zungu

  • Joyce Balagadde Kambugu

  • Stijn Verhulst

  • Jaques van Heerden

  • January 19, 2026

  • 0 min

Share

  • 1

    Pediatric acute myeloid leukemia (AML) constitutes 20-25% of acute leukemia cases globally, with significant incidence variations by region and age.

  • 2

    In Uganda, the true burden of pediatric AML is underreported due to lack of a national cancer registry and diagnostic challenges.

  • 3

    Diagnosis of AML in Uganda primarily relies on clinical assessment and bone marrow morphology due to limited access to advanced diagnostic tools.

  • 4

    The study reviewed 219 pediatric AML cases from three cancer treatment centers in Uganda, highlighting the need for improved data collection.

  • 5

    Understanding the clinical and laboratory profiles of pediatric AML is crucial for timely diagnosis and better outcomes in resource-limited settings.

Original Source(s)

Epidemiology, clinical manifestations, and hematological features of pediatric acute myeloid leukemia in Uganda: a retrospective study

  • by Richard Nyeko, Mariana Kruger, Nixon Niyonzima, Barnabas Atwiine, Jennifer Zungu, Joyce Balagadde Kambugu, Stijn Verhulst, Jaques van Heerden

  • January 19, 2026

Related Content

Severe asparaginase-associated hypertriglyceridemia in pediatric acute lymphoblastic leukemia: a single-center experience

Cerebrovascular thrombosis during pediatric ALL therapy: a case series highlighting temporal association with PEG-asparaginase exposure

ABO gene polymorphisms: a molecular bridge linking disease susceptibility to therapeutic outcomes